Clinical Trials · NCT07855900

SYNCHRONIZE®-START- A Study to Test Whether Survodutide Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight

Name: SYNCHRONIZE®-START- A Study to Test Whether Survodutide Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

Not Yet RecruitingPhase 3Survodutide Tirzepatide Semaglutide

Phase: Phase 3
Recruitment status: Not Yet Recruiting
Sponsor: Boehringer Ingelheim
Enrollment: 350
Start date: Nov 2026
Locations: 1 site, United States
Primary endpoint: Percent change in body weight from baseline to Week 52

View Survodutide compound reference